A detailed history of Almitas Capital LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Almitas Capital LLC holds 16,000 shares of FLGT stock, worth $263,360. This represents 0.14% of its overall portfolio holdings.

Number of Shares
16,000
Holding current value
$263,360
% of portfolio
0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$16.71 - $22.68 $267,360 - $362,880
16,000 New
16,000 $295,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $498M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Almitas Capital LLC Portfolio

Follow Almitas Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Almitas Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Almitas Capital LLC with notifications on news.